Charles River Laboratories, a leading provider of preclinical drug development services, has reported impressive results in ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing ...

Makers of organoids and cell models cheered the decision and said it will bolster the development of precision medicines, ...

Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, published on major advances to Enchant, Iambic’s ...

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...

The impetus: an announcement from the US Food and Drug Administration in early April indicating that the agency plans to phase out animal tests—a longtime cornerstone of preclinical drug testing ...

The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

Iambic’s breakthrough multimodal transformer model for predicting clinical and preclinical endpoints related to the drug discovery and development process. This new version of Enchant marks a ...